- Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
- ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
- ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
- Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
- Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
More ▼
Key statistics
As of last trade, Enzo Biochem Inc (ENZ:NYQ) traded at 1.15, 16.15% above the 52 week low of 0.9901 set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.17 |
---|---|
High | 1.17 |
Low | 1.12 |
Bid | 1.14 |
Offer | 1.15 |
Previous close | 1.17 |
Average volume | 106.51k |
---|---|
Shares outstanding | 51.46m |
Free float | 39.06m |
P/E (TTM) | -- |
Market cap | 60.21m USD |
EPS (TTM) | -0.3516 USD |
Data delayed at least 15 minutes, as of Jul 25 2024 17:38 BST.
More ▼